Amanote Research
Register
Sign In
Optimizing Cardiovascular and Chemopreventive Benefits of Aspirin: What Role for the Proton-Pump Inhibitors?
Alimentary Pharmacology and Therapeutics
- United Kingdom
doi 10.1111/j.1365-2036.2004.02347.x
Full Text
Open PDF
Abstract
Available in
full text
Categories
Hepatology
Pharmacology
Gastroenterology
Date
March 1, 2005
Authors
J. SCHEIMAN
Publisher
Wiley
Related search
Proton-Pump Inhibitors for the Treatment of Functional Dyspepsia
Therapeutic Advances in Gastroenterology
Gastroenterology
Proton Pump Inhibitors and Gastric Neoplasia
Gut
Gastroenterology
Community-Acquired Pneumonia and Proton Pump Inhibitors
Journal of General Internal Medicine
Internal Medicine
Interaction Between Clopidogrel and Proton Pump Inhibitors
CMAJ
Medicine
Proton Pump Inhibitors and Osteoporosis-Related Fractures
CMAJ
Medicine
Proton Pump Inhibitors in Kidney Disease
Clinical Journal of the American Society of Nephrology
Epidemiology
Nephrology
Critical Care
Transplantation
Intensive Care Medicine
The Prevalance of Coadministration of Clopidogrel and Proton Pump Inhibitors
Journal of Health and Allied Sciences
The Relationship Between Proton Pump Inhibitors and Renal Disease
Jornal brasileiro de nefrologia : orgão oficial de Sociedades Brasileira e Latino-Americana de Nefrologia
Medicine
Gastroprotection With Proton-Pump Inhibitors in High-Risk Cardiovascular Patients: Who to Target and for How Long?
Expert Opinion on Drug Safety
Medicine
Pharmacology